S&P 500   5,051.41 (-0.21%)
DOW   37,798.97 (+0.17%)
QQQ   431.10 (+0.01%)
AAPL   169.38 (-1.92%)
MSFT   414.58 (+0.23%)
META   499.76 (-0.09%)
GOOGL   154.40 (-0.30%)
AMZN   183.32 (-0.16%)
TSLA   157.11 (-2.71%)
NVDA   874.15 (+1.64%)
AMD   163.46 (+1.96%)
NIO   3.81 (-2.06%)
BABA   69.61 (-1.43%)
T   16.09 (-0.92%)
F   12.09 (-1.14%)
MU   121.77 (+0.33%)
GE   156.76 (+1.99%)
CGC   6.70 (-4.01%)
DIS   113.88 (+0.82%)
AMC   2.72 (+10.12%)
PFE   25.69 (-0.85%)
PYPL   63.43 (-0.13%)
XOM   118.69 (-0.83%)
S&P 500   5,051.41 (-0.21%)
DOW   37,798.97 (+0.17%)
QQQ   431.10 (+0.01%)
AAPL   169.38 (-1.92%)
MSFT   414.58 (+0.23%)
META   499.76 (-0.09%)
GOOGL   154.40 (-0.30%)
AMZN   183.32 (-0.16%)
TSLA   157.11 (-2.71%)
NVDA   874.15 (+1.64%)
AMD   163.46 (+1.96%)
NIO   3.81 (-2.06%)
BABA   69.61 (-1.43%)
T   16.09 (-0.92%)
F   12.09 (-1.14%)
MU   121.77 (+0.33%)
GE   156.76 (+1.99%)
CGC   6.70 (-4.01%)
DIS   113.88 (+0.82%)
AMC   2.72 (+10.12%)
PFE   25.69 (-0.85%)
PYPL   63.43 (-0.13%)
XOM   118.69 (-0.83%)
S&P 500   5,051.41 (-0.21%)
DOW   37,798.97 (+0.17%)
QQQ   431.10 (+0.01%)
AAPL   169.38 (-1.92%)
MSFT   414.58 (+0.23%)
META   499.76 (-0.09%)
GOOGL   154.40 (-0.30%)
AMZN   183.32 (-0.16%)
TSLA   157.11 (-2.71%)
NVDA   874.15 (+1.64%)
AMD   163.46 (+1.96%)
NIO   3.81 (-2.06%)
BABA   69.61 (-1.43%)
T   16.09 (-0.92%)
F   12.09 (-1.14%)
MU   121.77 (+0.33%)
GE   156.76 (+1.99%)
CGC   6.70 (-4.01%)
DIS   113.88 (+0.82%)
AMC   2.72 (+10.12%)
PFE   25.69 (-0.85%)
PYPL   63.43 (-0.13%)
XOM   118.69 (-0.83%)
S&P 500   5,051.41 (-0.21%)
DOW   37,798.97 (+0.17%)
QQQ   431.10 (+0.01%)
AAPL   169.38 (-1.92%)
MSFT   414.58 (+0.23%)
META   499.76 (-0.09%)
GOOGL   154.40 (-0.30%)
AMZN   183.32 (-0.16%)
TSLA   157.11 (-2.71%)
NVDA   874.15 (+1.64%)
AMD   163.46 (+1.96%)
NIO   3.81 (-2.06%)
BABA   69.61 (-1.43%)
T   16.09 (-0.92%)
F   12.09 (-1.14%)
MU   121.77 (+0.33%)
GE   156.76 (+1.99%)
CGC   6.70 (-4.01%)
DIS   113.88 (+0.82%)
AMC   2.72 (+10.12%)
PFE   25.69 (-0.85%)
PYPL   63.43 (-0.13%)
XOM   118.69 (-0.83%)

Cellect Biotechnology (APOP) News Today

Notice: This company has been marked as potentially delisted and may not be actively trading.
SourceHeadline
wsj.com logoKrystal Biotech Inc.
wsj.com - March 1 at 7:20 PM
bizjournals.com logoRaleigh/Durham Biotech News
bizjournals.com - June 23 at 3:14 PM
seekingalpha.com logoSana Biotechnology Is Technically Overbought So Buy It Later
seekingalpha.com - April 19 at 1:39 PM
cnbc.com logoPiper Sandler says this biotech stock can outperform thanks to Alzheimer's treatment
cnbc.com - April 19 at 1:39 PM
benzinga.com logo$3M Bet On This Biotechnology Stock? Check Out These 3 Penny Stocks Insiders Are Buying
benzinga.com - February 23 at 7:16 AM
finance.yahoo.com logoGlobal Agricultural Biotechnology Market to Reach $88.9 Billion by 2030
finance.yahoo.com - January 30 at 8:47 PM
morningstar.com logoWhy These Biotech Stocks Are Outperforming the Market
morningstar.com - November 24 at 11:29 AM
realmoney.thestreet.com logoSeeing Good Action in Biotechnology Stocks
realmoney.thestreet.com - November 16 at 10:50 PM
fool.co.uk logoInvesting in Biotech: Top UK Biotech Stocks in 2022
fool.co.uk - September 18 at 6:26 PM
finance.yahoo.com logoQuoin Pharmaceuticals Appoints Gordon Dunn as Chief Financial Officer
finance.yahoo.com - November 4 at 12:54 PM
finance.yahoo.com logoQuoin Pharmaceuticals Announces Signing of Exclusive License from Queensland University of Technology, Australia
finance.yahoo.com - November 2 at 1:02 PM
apnews.com logoCellect Biotechnology Announces Record Date and Distribution Date for CVRs in Connection with ...
apnews.com - October 16 at 1:24 PM
finance.yahoo.com logoCellect Biotechnology Announces Record Date and Distribution Date for CVRs in Connection with Strategic Merger with Quoin Pharmaceuticals
finance.yahoo.com - October 15 at 8:26 PM
finanznachrichten.de logoCellect Biotechnology Ltd.: Cellect Biotechnology Announces Shareholder Approval of Strategic Merger with Quoin Pharmaceuticals
finanznachrichten.de - October 14 at 7:23 PM
benzinga.com logoWhy Cellect Biotechnology Shares Are Rising Today
benzinga.com - September 27 at 5:31 PM
finance.yahoo.com logoCellect Biotechnology Announces Shareholder Approval of Strategic Merger with Quoin Pharmaceuticals
finance.yahoo.com - September 27 at 12:30 PM
marketbeat.com logo
marketbeat.com - September 27 at 10:10 AM
markets.businessinsider.com logoPre-market Movers: APOP, FBRX, ANY, AGIL, ADXS…
markets.businessinsider.com - September 3 at 7:43 AM
finance.yahoo.com logoCellect Biotechnology Announces the ApoGraft™ Bone Marrow Transplantation of First Patient in U.S.
finance.yahoo.com - September 2 at 4:41 PM
finance.yahoo.com logoCellect Biotechnology Reports Second Quarter 2021 Financial and Operating Results
finance.yahoo.com - August 24 at 9:01 PM
apnews.com logoThe Securities and Exchange Commission Declared Cellect Biotechnology’s Registration Statement ...
apnews.com - August 13 at 5:08 PM
finance.yahoo.com logoThe Securities and Exchange Commission Declared Cellect Biotechnology’s Registration Statement Filed on Form F-4 Effective in Connection with its Previously Announced Strategic Merger with Quoin Pharmaceuticals
finance.yahoo.com - August 13 at 5:08 PM
nasdaq.com logoCellect Biotechnology Ltd. American Depositary Shares (APOP)
nasdaq.com - July 27 at 11:22 PM
Get Cellect Biotechnology News Delivered to You Automatically

Sign up to receive the latest news and ratings for APOP and its competitors with MarketBeat's FREE daily newsletter.

Can't believe it's happening again (Ad)

One of the single most unique and powerful events in the markets is coming in the next two months. It’s scheduled for April 22, 2024. But investors are moving now to get ahead of what’s coming… driving up prices of one asset dramatically. And you should do the same.

We explain how this event works in full right here.

APOP Media Mentions By Week

APOP Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

APOP
News Sentiment

0.00

0.66

Average
Medical
News Sentiment

APOP News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

APOP Articles
This Week

0

0

APOP Articles
Average Week

Get Cellect Biotechnology News Delivered to You Automatically

Sign up to receive the latest news and ratings for APOP and its competitors with MarketBeat's FREE daily newsletter.


Related Companies and Tools

This page (NASDAQ:APOP) was last updated on 4/16/2024 by MarketBeat.com Staff

From Our Partners